Purchase Order 75P00120P00116
Award Date
3/18/20
Potential Completion Date
8/14/20
Potential Value
$4.6M
Federal Agency
Office of the Assistant Secretary for Administration
Ultimate Awardee
Laboratory Corporation Of America Holdings
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20201, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded Laboratory Corporation of America a $12.99 million firm fixed-price purchase order to provide COVID-19 laboratory testing services from May 6, 2020 through July 31, 2020 under a ratification action. The purpose of the purchase order was to ratify laboratory testing performed for HHS under Contract BTS 1.0 from the initial period of need. As the prime contractor, Laboratory Corporation of...
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Laboratory Corporation of America Holdings, a global life sciences company. The $169,142.60 firm-fixed-price purchase order is to support the supply of COVID-19 at-home test kits for fiscal year 2020. The contract does not have a set-aside designation. Laboratory Corporation of America Holdings has previously provided serology testing...
This $149,949.15 firm fixed price delivery order was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Laboratory Corporation of America for COVID-19 testing services for FDA employees and contractors. The contract has a period of performance through July 18, 2023 and no set-aside designation was used. As the largest commercial clinical laboratory network in the world, Laboratory Corporation of America will leverage its extensive experience and...
This purchase order ratifies a previous contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Quest Diagnostics Incorporated for COVID-19 laboratory testing services. The contract value is $6.5 million and provides testing from March 18, 2020 through July 31, 2020. As the prime contractor, Quest Diagnostics will deliver coronavirus diagnostic and surveillance testing to support the Office of the Assistant Secretary for...
This is a $91,693,500.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for COVID-19 laboratory testing services. The contract has an ultimate completion date of April 22, 2025 and is not set aside for small businesses. Labcorp, a leading global life sciences company, will provide comprehensive diagnostic testing and medical laboratory services to support various federal government healthcare...
The Department of Health and Human Services Food and Drug Administration awarded a $190,775 firm fixed price delivery order contract to Laboratory Corporation of America Holdings for COVID-19 testing for 2,500 ORA employees. As the parent company of Laboratory Corporation of America, the prime contractor awarded, Laboratory Corporation of America will provide coronavirus testing to support FDA inspectional activities. No set-aside designation was used for this contract awarded on September 15,...
This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Laboratory Corporation Of America Holdings, a global life sciences leader that provides laboratory diagnostic services. The contract is for HLA testing services, with a potential value of $587,926.66 and a completion date of March 31, 2023. The contract is not set-aside. Laboratory Corporation Of America Holdings has previously provided serology testing services to support COVID-19 response efforts...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $300,054.00 firm fixed price purchase order contract to Laboratory Corporation of America (LabCorp) to provide laboratory testing services. The contract has an end date of April 30, 2021 and was not set aside for any specific business types. LabCorp, a for-profit organization, is the prime contractor and has previously received other federal contract awards, including work as a...
This delivery order, awarded by the Department of Health and Human Services' Food and Drug Administration, is for $20,069.53 to provide COVID-19 testing for FDA employees and contractors. The prime contractor is Laboratory Corporation of America of Burlington, North Carolina, a subsidiary of Laboratory Corporation of America Holdings. The firm fixed price order is for coronavirus disease 2019 testing services to support the FDA's mission during the ongoing pandemic. No set-aside designation...
This federal contract award is a definitive contract valued at $1,974,948.75 issued by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Laboratory Corporation Of America Holdings, a global life sciences company. The contract is not set aside and is for the provision of laboratory diagnostic services, including serology testing to support the CDC's COVID-19 response efforts. Laboratory Corporation Of America Holdings has experience providing...